HPV Vaccine Coverage Increase
Recently published data from the CDC shows gains in HPV vaccine coverage:
In 2019, 71.5% of adolescents aged 13–17 years had received ≥1 dose of HPV vaccine, and 54.2% had completed the HPV vaccination series and were considered HPV UTD. Increases from 2018 in ≥1 dose HPV vaccine coverage and HPV UTD status were observed for females and for males.
HPV vaccination initiation by age 13 years increased an average of 5.3 percentage points for each consecutive birth year, from 19.9% among adolescents born in 1998 to 62.6% among those born in 2006. Being HPV UTD by age 13 years increased an average of 3.4 percentage points for each consecutive birth year, from 8.0% among adolescents born in 1998 to 35.5% among those born in 2006.
Updates from the National HPV Vaccination Roundtable
In July, the National HPV Vaccination Roundtable invited health systems and immunizers to join webinar discussions on the impact of COVID-19 on adolescent vaccination. These conversations were summarized into a new promising practices document for all organizations looking to get adolescent immunization back on track.
The document provides guidance on optimizing patient data, reminding and scheduling patients, patient outreach, staff education, visit and workflow options, and provides links to several state media campaigns. The document is short (8 pages), concise, and easy to read, and it provides actionable advice and links. Download it here.
CDC Updates Webpage and Infographic: HPV Cancers are Preventable
In September, the CDC updated data on its webpage HPV Cancers are Preventable. The page includes links to more information about cervical cancers, cervical precancers, and other HPV cancers as well as the number of cases of each per year. In addition, the infographic “HPV Iceberg” has been updated to reflect current data. The infographic is a powerful visual tool about HPV cancers and prevention. Download it here.